Collins Helen Louise
Kura Oncology, Inc. · Director
Collins Helen Louise is listed in filings as Director at Kura Oncology, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Kura Oncology, Inc. (KURA), Enliven Therapeutics, Inc. (ELVN), and IO Biotech, Inc. (IOBT). The current snapshot covers public activity from Oct 22, 2024 to Jun 4, 2026. Reported amounts are shown as $306.9K to $52.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $137k3.5k shares | SellMay 18, 2026 | $39.53 | $53.20 | |
| $52k1.3k shares | SellMay 18, 2026 | $40.25 | $53.20 | |
| $9.2k223 shares | SellMay 18, 2026 | $41.21 | $53.20 |